Randomised, Double-Blind, Placebo Controlled, Cross Over Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
Completed
- Conditions
- Adrenomyeloneuropathy (AMN)Nervous System Diseases
- Registration Number
- ISRCTN48334111
- Lead Sponsor
- ReceptoPharm Inc. (USA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
1. Male or female age =18 years
2. Diagnosis of AMN either biochemically or genetically
3. Have some motor disability that affects their gait
4. Willing and able to provide written informed consent
5. Willing and able to comply with study procedures
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration. <br>
- Secondary Outcome Measures
Name Time Method ot provided at time of registration. <br>